Many cancer treatment methods, such as chemotherapy, are broad swords attacking tissues other than just the cancer cells, causing suffering and sometimes organ failure with the patients. A more targeted approach is being developed by Dr. Gunning's research group where anti-cancer molecules latch onto the key proteins in cancer cells – turning off the tumour growing process.
“Our goal is that these molecules will allow people to have a less aggressive cancer therapy regimes, and will prevent tumours from coming back,” says Dr. Gunning.
TurboVap® in German
Biotage Acquires Horizon Technology
Extraction of Acidic Catecholamine Metabolites in Plasma Using ISOLUTE® SLE+ Prior to LC-MS/MS Analysis
Video Demonstration: Multi Racks for TurboVap®
Effective Purification of Peptides using Normal Phase Flash